Pulmonary pharmacology is a specialized field focusing on the study of drug interactions within the respiratory system. Pharmacodynamics in this context explores how drugs exert their effects on pulmonary tissues and functions. It involves understanding the dynamic relationship between drugs and their molecular targets, emphasizing the specific mechanisms by which medications influence respiratory processes.
In the realm of pulmonary pharmacodynamics, researchers investigate how drugs impact bronchial smooth muscle tone, airway resistance, and pulmonary blood vessels. This knowledge is crucial for developing therapies for respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. By unraveling the intricate molecular interactions between drugs and pulmonary receptors, pharmacologists aim to optimize treatment outcomes while minimizing adverse effects. The evolving landscape of pulmonary pharmacodynamics continues to pave the way for innovative therapies that enhance respiratory function and improve the quality of life for individuals with pulmonary disorders.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia